Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
Shigeru Kotake(Tokyo Women's Medical University), Sadao Kashiwazaki(Tokyo Women's Medical University), Nobuyuki Udagawa(Matsumoto Dental University), Kang Jung Kim(Tokyo Women's Medical University), Akira Yamaguchi(The University of Melbourne), Ichiro Nakamura(Showa University), Tatsuo Suda(SHOWA Medical University), Tadamitsu Kishimoto(Osaka International University), Naoyuki Takahashi(Tohoku University), Kazuto Sato(Tokyo Women's Medical University)
Cited by 548
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Interleukin-6 family of cytokines and gp130
|Blood|1995|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665